loader
Please Wait
Applying Filters...
menu
    • menu

    Digital Content for Acamprosate

    Client Email Product
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    Menu

    Acamprosate

    ACTIVE PHARMA INGREDIENTS

    PRICE INFORMATION

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 136Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Obesity drugs don't make WHO's essential list, but Ebola, MS drugs added
    Obesity drugs don't make WHO's essential list, but Ebola, MS drugs added

    27 Jul 2023

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/obesity-drugs-dont-make-whos-essential-list-ebola-ms-drugs-added-2023-07-26/

    REUTERS
    27 Jul 2023
    Share Share
    World first clinical trial commences in alcohol use disorder
    World first clinical trial commences in alcohol use disorder

    28 Oct 2019

    // BIOSPECTRUMASIA

    https://www.biospectrumasia.com/news/39/14759/world-first-clinical-trial-commences-in-alcohol-use-disorder.html

    BIOSPECTRUMASIA
    28 Oct 2019
    Share Share
    Galapagos, Pharnext join forces to develop drug combos
    Galapagos, Pharnext join forces to develop drug combos

    11 Mar 2017

    // NP Taylor FIERCE BIOTECH

    http://www.fiercebiotech.com/biotech/galapagos-pharnext-join-forces-to-develop-drug-combos

    NP Taylor FIERCE BIOTECH
    11 Mar 2017
    Share Share
    Angelini Fine Chemicals: new synthesis technologies to broaden the offer
    Angelini Fine Chemicals: new synthesis technologies to broaden the offer

    01 Nov 2016

    // PRESS RELEASE

    http://www.angelinipharma.com/wps/wcm/connect/com/home/angelini-news/angelini-fine-chemicals-new-synthesis-technologies-to-broaden-the-offer

    PRESS RELEASE
    01 Nov 2016
    Share Share